Comprehensive medical diagnostics company Todos Medical Ltd (OTCMKTS:TOMDF) on August 26, 2022, announced that the Atlanta-area CLIA/CAP-certified clinical laboratory Provista Diagnostics Inc is now giving saliva-only MonkeyPox testing.
Trading Data
On Friday, TOMDF stock surged 9.46% to $0.0405 with more than 15.48 million shares, compared to its average volume of 8.90 million shares. The stock moved within a range of $0.0350 – 0.0420 after opening trade at $0.0380.
Todos Medical Announces Saliva-Only MonkeyPox Testing at CLIA/CAP Clinical Lab Provista Diagnostics
Samples must be stored in the refrigerator within an hour of collection and can be shipped with cold packs. The turnaround time of the result is 24-48 hours from the time of arrival of the sample. The test aims to be used in suspected cases of MonkeyPox without lesions.
Gerald E. Commissiong, President & CEO of Todos Medical said that the scaling up of pre-symptomatic MonkeyPox testing demonstrates a game-changing event in the country’s ability to contain the MonkeyPox outbreak. The CEO added that the MonkeyPox hasn’t impacted the country for decades due to quick containment. Commission added that the company has tests available to identify community spread early and reduce risks to children.
Key Quote
“We believe the scaling up of pre-symptomatic MonkeyPox testing before lesions fully develop that can be swabbed, represents a game-changing event in the nation’s ability to contain outbreaks of MonkeyPox,” said Gerald E. Commissiong, President & CEO of Todos Medical.
Todos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study Series
Todos Medical Ltd on August 25, 2022, announced that the Atlanta-area CLIA/CAP-certified clinical laboratory Provista Diagnostics Inc enrolled female Long COVID. The patient, who was denied testing has now been prescribed TPoxx.
Provista received samples collected before TPoxx administration and will analyze the MonkeyPox effect. The firm believes it is essential for schools to plan for PCR-based COVID surveillance testing and MonkeyPox testing.
Currently, there are more than 30 million children in middle and elementary schools in the United States and 16 million children enrolled in high schools.
Technical Data
TOMDF stock is trading above the 20-Day and 50-Day Moving averages of $0.0285 and $0.0186 respectively. Moreover, the stock is trading above the 200-Day moving average of $0.0310. The company has a total market capitalization of $48 million.
